NurExone Biologic

About:

NurExone Biologic is developing a biological exosome based technology drug platform to treat damage in the Central Nerve System.

Website: https://nurexone.com

Twitter/X: NBiologic

Top Investors: Israel Innovation Authority

Description:

Total Funding Amount:

$2.6M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Haifa, Hefa, Israel

Founded Date:

2020-01-01

Contact Email:

info(AT)nurexone.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2024-09-26

IPO Status:

Public

Industries: